Alcon (MEX:ALC N) EBIT: MXN21,808 Mil (TTM As of Mar. 2026)


MEX:ALC N Alcon Inc MEX:ALC N
73 GF Score
Price MXN1,158.62
GF Value MXN1,750.95
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Alcon EBIT?

Alcon MEX:ALC N 73 EBIT is MXN21,808 Mil as of Mar. 2026. GuruFocus rates MEX:ALC N with a GF Score™ of 73/100 and a GF Value™ of MXN1,750.95 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Alcon's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was MXN5,266 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN21,808 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Alcon's annualized ROC % for the quarter that ended in Mar. 2026 was 3.10%. Alcon's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 20.72%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Alcon's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 3.36%.


Alcon  (MEX:ALC N) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Alcon's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=21062.192 * ( 1 - 21.25% )/( (551496.586 + 519936.84)/ 2 )
=16586.4762/535716.713
=3.10 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=568169.864 - 16673.278 - ( 0 - max(0, 54899.379 - 116118.759+0))
=551496.586

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=570175.942 - 20322.853 - ( 29916.249 - max(0, 54170.231 - 119376.474+29916.249))
=519936.84

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Alcon's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=21062.192/( ( (0 + max(62659.836, 0)) + (94184.792 + max(46452.236, 0)) )/ 2 )
=21062.192/( ( 62659.836 + 140637.028 )/ 2 )
=21062.192/101648.432
=20.72 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 43051.629 + 73067.13) - (16673.278 + 0 + 36785.645)
=62659.836

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(35722.779 + 43963.723 + 9250.775) - (20322.853 + 0 + 22162.188)
=46452.236

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Alcon's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=21807.618/648805.350
=3.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alcon EBIT Related Terms


Alcon EBIT Historical Data

* Premium members only.

The historical data trend for Alcon's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alcon EBIT Chart

Alcon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,036.53 11,639.11 17,330.71 30,199.05 24,559.78

Alcon Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,472.15 4,707.30 6,126.96 5,707.81 5,265.55

MEX:ALC N vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Alcon's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alcon EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Alcon's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Alcon's EV-to-EBIT falls into.


MEX:ALC N
73GF Score
Alcon Inc MEX:ALC N
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alcon EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN21,808 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of MXN21,808 Mil mean?
Alcon (MEX:ALC N) has a EBIT of MXN21,808 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Alcon.
Is Alcon's EBIT too high?
Alcon's current EBIT is MXN21,808 Mil. Overall, Alcon has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alcon's EBIT compare to ISRG and BDX?
Alcon's EBIT of MXN21,808 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Alcon. Alcon's current EBIT is MXN21,808 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcon stock overvalued right now?
Based on GuruFocus' analysis, Alcon (MEX:ALC N) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,750.95, compared to a current price of MXN1,158.62 — trading 33.8% below its estimated fair value. The current EBIT is MXN21,808 Mil. Alcon's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Alcon (MEX:ALC N), the current EBIT is MXN21,808 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alcon (MEX:ALC N) Overvalued in 2026?

Based on GuruFocus' analysis, Alcon stock appears to be undervalued. The current stock price of MXN1,158.62 is trading 33.8% below its estimated GF Value™ of MXN1,750.95. GuruFocus considers Alcon to be Significantly Undervalued.

Key valuation signals for MEX:ALC N:

  • EBIT: MXN21,808 Mil
  • GF Value™: MXN1,750.95 vs. price of MXN1,158.62 (33.8% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the MEX:ALC N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alcon Business Description

Address Chemin de Blandonnet 8, Vernier, Geneva, CHE, 1214
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
73GF Score

Get the complete analysis for MEX:ALC N

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,158.62
Price
MXN1,750.95
GF Value